BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31256027)

  • 1. Prevalence of antimicrobial use and active healthcare-associated infections in acute care hospitals: a multicentre prevalence survey in Japan.
    Komagamine J; Yabuki T; Kobayashi M; Okabe T
    BMJ Open; 2019 Jun; 9(6):e027604. PubMed ID: 31256027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
    Plachouras D; Kärki T; Hansen S; Hopkins S; Lyytikäinen O; Moro ML; Reilly J; Zarb P; Zingg W; Kinross P; Weist K; Monnet DL; Suetens C;
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey.
    Loftus MJ; Curtis SJ; Naidu R; Cheng AC; Jenney AWJ; Mitchell BG; Russo PL; Rafai E; Peleg AY; Stewardson AJ
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):146. PubMed ID: 32859255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point prevalence of healthcare-associated infections and antibiotic use in three large Swiss acute-care hospitals.
    Metsini A; Vazquez M; Sommerstein R; Marschall J; Voide C; Troillet N; Gardiol C; Pittet D; Zingg W; The Swissnoso Network
    Swiss Med Wkly; 2018; 148():w14617. PubMed ID: 29698542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study.
    Morioka H; Hirabayashi A; Iguchi M; Tomita Y; Kato D; Sato N; Hyodo M; Kawamura N; Sadomoto T; Ichikawa K; Inagaki T; Kato Y; Kouyama Y; Ito Y; Yagi T
    Am J Infect Control; 2016 Jul; 44(7):e119-23. PubMed ID: 27372390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022.
    Antonelli A; Ales ME; Chiecca G; Dalla Valle Z; De Ponti E; Cereda D; Crottogini L; Renzi C; Signorelli C; Moro M
    BMC Infect Dis; 2024 Jun; 24(1):632. PubMed ID: 38918691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare-associated infections point prevalence survey and antimicrobials use in acute care hospitals (PPS 2016-2017) and long-term care facilities (HALT-3): a comprehensive report of the first experience in Molise Region, Central Italy, and targeted intervention strategies.
    Ripabelli G; Salzo A; Mariano A; Sammarco ML; Tamburro M;
    J Infect Public Health; 2019; 12(4):509-515. PubMed ID: 30745199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey.
    Palaiopanos K; Krystallaki D; Mellou K; Kotoulas P; Kavakioti CA; Vorre S; Vertsioti G; Gkova M; Maragkos A; Tryfinopoulou K; Paraskevis D; Tsiodras S; Zaoutis T
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):11. PubMed ID: 38273402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare-associated infections and antimicrobial use in long-term care facilities (HALT3): an overview of the Italian situation.
    Furmenti MF; Rossello P; Bianco S; Olivero E; Thomas R; Emelurumonye IN; Zotti CM;
    J Hosp Infect; 2019 Aug; 102(4):425-430. PubMed ID: 30790605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.
    Zarb P; Coignard B; Griskeviciene J; Muller A; Vankerckhoven V; Weist K; Goossens M; Vaerenberg S; Hopkins S; Catry B; Monnet D; Goossens H; Suetens C; ;
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and rationale for antimicrobial prescription during ambulatory care visits in Japan: a prospective, multicentre, cross-sectional study.
    Komagamine J; Kobayashi M; Mori T
    BMJ Open; 2020 Aug; 10(8):e039329. PubMed ID: 32843518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals.
    Frenette C; Sperlea D; German GJ; Afra K; Boswell J; Chang S; Goossens H; Grant J; Lefebvre MA; McGeer A; Mertz D; Science M; Versporten A; Thirion DJG
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):104. PubMed ID: 32653046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring healthcare-associated infections and antimicrobial use at regional level through repeated point prevalence surveys: what can be learnt?
    Arnoldo L; Smaniotto C; Celotto D; Brunelli L; Cocconi R; Tignonsini D; Faruzzo A; Brusaferro S;
    J Hosp Infect; 2019 Apr; 101(4):447-454. PubMed ID: 30597175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare infections and antimicrobial consumption in pre-COVID-19 era: a point prevalence survey in three hospitals in a region of Central Italy.
    Tamburro M; Salzo A; Sammarco ML; Ripabelli G
    J Prev Med Hyg; 2023 Dec; 64(4):E463-E470. PubMed ID: 38379748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial use in acute care hospitals: national point prevalence survey on healthcare-associated infections and antimicrobial use, Switzerland, 2017.
    Zingg W; Metsini A; Gardiol C; Balmelli C; Behnke M; Troillet N; Widmer A; Pittet D;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of healthcare-associated infections and antimicrobial use in China: Results from the 2018 point prevalence survey in 189 hospitals in Guangdong Province.
    Zhang Y; Zhong ZF; Chen SX; Zhou DR; Li ZK; Meng Y; Zhou JF; Hou TY
    Int J Infect Dis; 2019 Dec; 89():179-184. PubMed ID: 31580939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial therapy, resistance, and appropriateness in healthcare-associated and community-associated infections; a point prevalence survey.
    Alsaedi AA; El-Saed A; Althaqafi A; Bhutta MJ; Abukhzam B; Alshamrani M
    J Infect Chemother; 2022 Oct; 28(10):1358-1363. PubMed ID: 35760663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011.
    Magill SS; Edwards JR; Beldavs ZG; Dumyati G; Janelle SJ; Kainer MA; Lynfield R; Nadle J; Neuhauser MM; Ray SM; Richards K; Rodriguez R; Thompson DL; Fridkin SK;
    JAMA; 2014 Oct; 312(14):1438-46. PubMed ID: 25291579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida.
    Magill SS; Hellinger W; Cohen J; Kay R; Bailey C; Boland B; Carey D; de Guzman J; Dominguez K; Edwards J; Goraczewski L; Horan T; Miller M; Phelps M; Saltford R; Seibert J; Smith B; Starling P; Viergutz B; Walsh K; Rathore M; Guzman N; Fridkin S
    Infect Control Hosp Epidemiol; 2012 Mar; 33(3):283-91. PubMed ID: 22314066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare-Associated Infections and Antibiotics Consumption: A Comparison of Point Prevalence Studies and Intervention Strategies.
    Salzo A; Ripabelli G; Sammarco ML; Mariano A; Niro C; Tamburro M
    Hosp Top; 2021; 99(3):140-150. PubMed ID: 33792522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.